118th Congress
Congresswoman Rosa DeLauro (CT-03) today reintroduced the Expanded Food Safety Investigation Act, legislation that would empower the Food and Drug Administration (FDA) with new authority to allow the investigation of corporate livestock feedlots and confinement operations implicated in foodborne illness outbreaks.
In observation of World Day Against Child Labor, U.S. Representative Rosa DeLauro (D-CT-03) and U.S.
Today, U.S. Representatives Rosa DeLauro (CT-03) and Debbie Wasserman Schultz announced they submitted a comment letter on the U.S. Preventive Services Task Force recommendations relating to breast cancer.
Today,U.S. Representatives Rosa DeLauro (CT-03), Suzan DelBene (WA-01), and Ritchie Torres (NY-15), reintroduced the American Family Act, legislation that would make permanent the expanded and improved monthly Child Tax Credit.
U.S. Representatives Rosa DeLauro, Joe Courtney, John B. Larson, Jim Himes, and Jahana Hayes and U.S. Senators Richard Blumenthal and Chris Murphy today announced their offices will host an informational session for Connecticut high school freshmen, sophomores and juniors to learn more about the Military Service Academies.
On Wednesday, DeLauro, Sanders, and Gillibrand also ralliedwith rail workers, mothers, union leaders, advocates, and colleagues around passing paid sick, family, and medical leave.
Far Too Many Americans Left Vulnerable With Paid Leave Legislation Enacted in Just 11 States and DC;
Nearly Every Single Worker Will Need Paid Leave At Some Point, Whether They Are Dealing With Another Pandemic Or A Personal Emergency
U.S. Representatives Rosa DeLauro (D-CT), Jenniffer González-Cólon (R-PR), Linda T. Sánchez (D-CA), Kim Schrier, M.D. (D-WA), and Brian Fitzpatrick (R-PA,) joined by Senators Bob Casey (D-PA) and Susan Collins (R-ME), introduced the Wise Investment in Children Act (WIC Act).
Glamour followed 8 women 28 days postpartum to show the true impact of the first month and the need for paid family and medical leave
Today, Congresswoman Rosa DeLauro (CT-03) released a statement in response to recommendations issued by the U.S. Preventive Services Task Force regarding breast cancer.